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Obstructive sleep apnea (OSA) has been linked to 
hypertension in several experimental, epidemiological, 
and clinical studies. Animal modes of sleep apnea have 
provided strong evidence for a causal relationship with 
hypertension.1 Studies in humans have demonstrated that 
patients with sleep apnea have an increased blood 
pressure and a higher incidence of hypertension.2-4  The 
most compelling evidence linking OSA and hypertension 
was provided by data from the Wisconsin Sleep Cohort 
Study.5 This study has demonstrated a dose-response 
association between sleep-disordered breathing at 
baseline and the presence of de novo hypertension 4 years 
later. 5 The odds ratios for the presence of hypertension at 
the 4-year follow-up study according to the apnea-
hypopnea index (AHI) at base line were estimated after 
adjustment for baseline hypertension status, body mass 
index (BMI), neck and waist circumference, age, gender, 
and weekly use of alcohol and tobacco. Relative to the 
reference category of an AHI of 0 events per hour at 
baseline, the odds ratios for the presence of hypertension 
at follow-up were 1.42 (95% confidence intervals-CI 
1.13-1.78) with an AHI of 0.1-4.9 events per hour at base 
line as compared with none, 2.03 (95% CI 1.29-3.17) 
with an AHI of 5.0-14.9 events per hour, and 2.89 (95% 
CI 1.46-5.64) with an AHI of 15.0 or more events per 
hour. These findings suggest two important concepts. 
First, sleep-disordered breathing is a risk factor for 
hypertension in the general population. Second, even 
sleep apnea that is considered mild may also contribute 
significantly to overall blood pressure levels. 
While the prevalence of sleep apnea increases with 
age, the link between sleep-disordered breathing and 
hypertension may be attenuated by aging.6 A recent 
analysis of the Sleep Heart Health Study 7 has shown that 
OSA is independently associated with hypertension in 
middle-aged subjects but not in elderly subjects. 
Interestingly, isolated systolic hypertension was not 
associated with sleep-disordered breathing. In those aged 
<60 years, AHI was significantly associated with higher 
odds of systolic/diastolic hypertension [odds ratio-
OR=2.38 (95% CI 1.30-4.38) for AHI 15-29; OR=2.24 
(95% CI 1.10-4.54) for AHI≥30]. Thus, taking into 
account age and distinguishing between hypertensive 
subtypes reveals a stronger association between sleep-
disordered breathing and hypertension for young and 
middle-aged subjects than previously reported.  
The prevalence of hypertension is underdiagnosed in 
OSA patients if blood pressure is assessed by office 
readings only. Baguet et al. 8 have shown that ambulatory 
blood pressure monitoring might be of particular 
significance in the hypertension diagnosis of OSA 
patients. While 42% of their OSA patients demonstrated 
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office hypertension, 58% had daytime hypertension, and 
76% had night time hypertension. Thus, OSA is 
characterised by a “non-dipping” pattern of hypertension, 
which itself has been associated with an adverse 
cardiovascular prognosis.9  
Obstructive sleep apnea increases the prevalence of 
target organ damage in patients with hypertension, and is 
an independent risk factor for the development of left 
ventricular hypertrophy.10 Furthermore, OSA affects 
functional and structural properties of large arteries 
contributing to hypertension and atherosclerosis 
progression. Middle-aged patients with OSA free of overt 
cardiovascular disease were shown to have increased 
pulse-wave velocity and increased intima-media 
thickness.11 Marked increases in transmural pressure of 
the aorta wall during obstructive events may contribute to 
the increased risk of thoracic aorta dissection in 
hypertensive patients. Indeed Sampol et al.12 have 
recently demonstrated a high prevalence of previously 
undiagnosed and frequently severe OSA in patients with 
thoracic aorta dissection. 
Furthermore, OSA has been linked with resistant 
hypertension, defined as hypertension refractory to at 
least three antihypertensive medications, one of which is 
a diuretic.13-15 Resistant hypertension has been reported in 
~12% among the hypertensive population.15 In a recent 
prospective study of 204 patients (mean age 48 years) 
with ambulatory daytime mean blood pressure >135/85 
mm Hg, the frequency of OSA was evaluated.15 Mild, 
moderate and severe OSA were present in 55 (27.0%), 38 
(18.6%) and 54 (26.5%) patients, respectively. 
Importantly, three comorbidities, OSA, metabolic 
syndrome and primary aldosteronism, were the most 
frequent conditions encountered. Fortunately, treatment 
of OSA with use of continuous positive airway pressure 
(CPAP) has a beneficial effect not only in lowering blood 
pressure but also in ameliorating additional concomitant 
risk factors. 16  Thus, OSA with its intermittent hypoxia 
should be sought and considered as a potentially 
modifiable risk factor in patients with hypertension, and 
particularly in those with resistant hypertension.  
 
AHI = apnea-hypopnea index (events per hour: 5-15 mild, 15-
30 moderate, >30 severe); OSA = obstructive sleep apnea 
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